Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?

NCT03009565 · clinicaltrials.gov ↗
UNKNOWN
Status
800
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rabin Medical Center

Collaborators